Framingham study braces for cuts

| | Cardiovascular Business | Structural Heart Disease

Boston University’s BU Today reported that the 65-year-old Framingham Heart Study will lose $4 million in federal funding under the sequester, forcing the layoffs of 19 staffers in November. In a video, Boston University biomedical engineer Ahmad S. Khalil, PhD, argues against the cuts on ScienceWorksforUS.org.

Framingham Heart Study carries on, despite budget cuts

Subscribe to Cardiovascular Business News

Related Content

First patients treated for TRIUMPH trial focused on new TTVR tech
Abbott now enrolling patients for new research on Cephea mitral valve replacement device
Long-term data support durability and sustained outcomes with balloon-expandable TAVR valves
Strokes after TAVR remain a problem: Key insights from new registry data
Is surgical backup still necessary during TAVR? Opinions are mixed as bailout risk decreases
TAVR linked to lower risk of in-hospital mortality than SAVR

Around the web

Health Exec
An inside look at the changing culture of the FDA
Health Exec
FDA balances faster AI adoption with safety as healthcare technology advances
Radiology Business
Maryland mammography law turns incidental cardiac findings into a new screening opportunity

Subscribe to Cardiovascular Business News

Subscribe to Cardiovascular Business News